Authors' objectives: Huntington's disease is a genetic condition that usually occurs in adults. It affects the central nervous system by damaging nerve cells in the brain. This causes problems with eyesight, movement, speaking and swallowing, and can also affect memory, moods and emotions. There is no cure for Huntington's disease, but there are treatments that can help control the symptoms. Pridopidine is a new drug which is given as a tablet to treat problems with movement in people who have Huntington's disease. Studies are currently underway to see how well it works and whether it is safe for patients to take. If pridopidine is licensed for use in the UK, it could offer a new treatment option for patients with Huntington's disease that may help with movement problems.

Project Status: Completed

Year Published: 2015

URL for published report: http://www.hsric.nihr.ac.uk/topics/pridopidine-huntexil-for-huntingtons-disease/

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: England, United Kingdom

Organisation Name: NIHR Horizon Scanning Centre

Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269

Contact Name: c.packer@bham.ac.uk

Contact Email: c.packer@bham.ac.uk

Copyright: NIHR Horizon Scanning Research&Intelligence Centre (NIHR HSRIC)